Form 4 for AZTA Azenta, Inc.

Accepted 2023-11-17 00:00:00 ET · period of report 2023-11-15 · accession 0001209191-23-055724 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2023-11-17	2023-11-15+	AZTA	Vacha Robin	SVP, GM Life Science Products	A - Grant	$54.36	+8,689	29.3K	+42%	+$472.4K
	2023-11-17	2023-11-16	AZTA	Vacha Robin	SVP, GM Life Science Products	D - Sale to Iss	$53.81	-2,946	26.4K	-10%	-$158.5K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-11-16	A	A	4,582	$54.57	30,963	D	—	—	(F3) Grant of restricted stock units to the Reporting Person under the Company's Long Term Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2024.
2	Common	Common Stock	2023-11-16	D	D	2,946	$53.81	26,381	D	—	—	(F2) The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2023 of 4,107 performance stock units and 2,755 of restricted stock units held by the reporting person.
3	Common	Common Stock	2023-11-15	A	A	4,107	$54.13	29,327	D	—	—	(F1) Represents shares issued upon the vesting of performance-based units granted on November 13, 2020, of which one-third was determined to be earned at 150% and converted into restricted stock units which vested on November 15, 2023. No amount was paid by the reporting person upon grant or vesting of the performance-based units.